Yuson, Robbie .
HRN: 23-84-47 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/05/2023
BENZYL PENICILLIN 5MU (VIAL)
10/05/2023
10/11/2023
IVT
1,500,000,000
Q6hrs
Viral Enceph
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes